UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

The UCLA Division of Plastic & Reconstructive Surgery

Print
Email
Share

Research Faculty

     
Christopher A. Crisera, MD, FACS
Associate Clinical Professor & Director of Microsurgery
   
 

Dr. Crisera's research focuses on clinical outcomes studies of breast reconstrunctions.  The goal of these studies is to dtermine which reconstructive technique(s) will offer individual patients the optmial outcome based on their medical history, risk factors, and co-morbidities.  Using the large volume of cases performed at UCLA as a data source, the statistics obtained from these studies will serve as a benchmark for other institutions across the country.

For more information about Dr. Crisera's ongoing work, click here.

 

 


Andrew L. Da Lio, MD, FACS
Clinical Professor & Chief

   
   

Dr. Da Lio's research focuses on microsurgery, objective assessment of abdominal wall function after free TRAM flap breast reconstruction, the use of nuclear medicine imaging (FDG-PET scanning) in differentiating benign and malignant lesions after breast reconstruction, and the role of decision analysis in breast reconstruction surgery.

For more information about Dr. Da Lio's ongoing work, click here.

 

 


Jaco H. Festekjian, MD, FACS
Clinical Professor
   
 

Dr. Festekjian's research focuses on clinical outcomes studies of breast reconstrunctions.  The goal of these studies is to dtermine which reconstructive technique(s) will offer individual patients the optmial outcome based on their medical history, risk factors, and co-morbidities.  Using the large volume of cases performed at UCLA as a data source, the statistics obtained from these studies will serve as a benchmark for other institutions across the country.

For more information about Dr. Festekjian's ongoing work, click here.

 

 


Reza Jarrahy, MD
Assistant Professor
   
 

Dr. Jarrahy's basic science research focuses on tissue engineered approaches to alveolar cleft reconstruction and cranioplasty, using novel rodent alveolar cleft models and critical calvarial defect models in rodents that are being reconstructed with resorbable plate/BMP-2 constructs.

He is also participating in a clinical outcomes study that compares open, endoscopic, and spring-assisted cranioplasty in patients with craniosynostosis.

For more information on Dr. Jarrahy's ongoing work, click here.

 

 


Timothy A. Miller, MD, FACS
Professor Emeritus

   
Timothy Miller, MD  

Dr. Miller's research focuses on bone tissue engineering at both molecular and tissue level. Using a well-known rabbit cranial defect model, his research team has tested a variety of different scaffolding materials and osteo-inductive agents for their ability to heal the defect in rabbits. They are working to develop a bone graft substitute (BGS) consist of PLGA scaffold, bone marrow stromal cells and recombinant BMP-2. While the BGS partially healed the defect, a large amount of BMP-2 is required. As widely acknowledged, the use of BMP-2 to repair large bony defects is cost prohibited.  Dr. Miller's laboratory is testing several alternatives to either replace BMP-2 with affordable small chemicals or enhance BMP-2 efficacy with naturally occurring peptides.

For more information on Dr. Miller's ongoing work, click here.

 

 


Chia Soo, MD
Professor & Vice Chair for Research

   
Chia Soo, MD  

Dr. Soo's research focuses on the regeneration of bone, cartilage, skin, and muscle using novel biologics and stem cells. Her publication record as a clinician-scientist reflects long-standing, multidisciplinary collaborations with scientists from molecular and developmental biology, stem cell biology, and bioengineering. She has a proven track record of successfully assembling and managing multi-investigator projects and has obtained funding from both Federal and non-Federal funding sources including the NIH (RO1s and SBIRs), the Department of Defense, and the State of California through the UC Discovery Grants and the California Institute for Regenerative Medicine (CIRM).

For more information on Dr. Soo's ongoing work, click here.

 

 


UCLA Rated One of the Top Hospitals in the Nation